Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDA, LHAA, and DA Regimens in Young Adults With Acute Myeloid Leukemia
NCT07651176Phase 3Enrolling by invitation
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Mar 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 3 trial of lisaftoclax in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Started Mar 2026; status: enrolling by invitation.
02
Drugs
lisaftoclax
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT07651176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07651176.